Ana
Rodríguez Regal
Complexo Hospitalario Universitario de Pontevedra
Pontevedra, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Pontevedra (11)
2023
-
Alemtuzumab treatment in real clinical practice: Experience in a multicenter cohort.
Multiple Sclerosis and Related Disorders, Vol. 75
-
Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193
-
Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis
Patient Preference and Adherence, Vol. 17, pp. 1431-1439
2021
-
Effectiveness of dimethyl fumarate in real-world clinical practice and strategy to minimize adverse effects and use of healthcare resources
Patient Preference and Adherence, Vol. 15, pp. 149-158
-
Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the “no evidence of disease activity” parameter
Neurologia, Vol. 36, Núm. 5, pp. 346-352
2016
-
Aseptic meningitis as a complication of immunoglobulin treatment in myasthenia gravis
Revista de Neurologia
-
Fingolimod: Efectividad y seguridad en la práctica clínica habitual. Estudio observacional,retrospectivo y multicéntrico en Galicia
Revista de Neurologia, Vol. 63, pp. S13-S18
-
Re: Myasthenia gravis and treatment with intravenous immunoglobulins
Revista de Neurologia
2009
-
Distonía en el curso de una encefalitis de Rasmussen de inicio tardío
Neurologia
-
Dystonia: Their epidemiology, aetiology, diagnosis and treatment
Revista de Neurologia, Vol. 48, Núm. SUPPL. 1
-
Estudio de casos y controles sobre la influencia del hábito tabáquico en la esclerosis múltiple
Neurologia, Vol. 24, Núm. 3, pp. 177-180